Berlin - Delayed Quote EUR

Getinge AB (GTN.BE)

16.53

+0.21

+(1.29%)

At close: January 17 at 8:09:43 AM GMT+1

Getinge installs surgical workflow portfolio at UT Health San Antonio in Texas

The installation aims to improve efficiency and patient safety across various care settings.

Hospital Management last month

GNGBY
Two hybrid ORs inaugurated in ASST Sette Laghi hospital, Italy

The multi-modality ORs are designed to cater to complex procedures.

Hospital Management last month

GNGBY
FDA warns providers on Getinge devices tied to 17 serious injuries

Getinge recalled endoscopic vessel harvesting devices after receiving 18 complaints in four months. The FDA added the devices to its shortages list following the recall.

MedTech Dive last month

GNGBY
Paragonix wins FDA nod for portable kidney perfusion device

The KidneyVault system is a hypothermic perfusion device with digital monitoring capabilities for preserving and transporting donor kidneys.

Medical Device Network 2 months ago

GNGBY
Getinge AB (GNGBF) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Getinge AB (GNGBF) reports strong order intake and strategic acquisitions, while addressing supply chain and margin pressures.

GuruFocus.com 2 months ago

GNGBY
Getinge completes Paragonix Technologies acquisition

Paragonix is engaged in developing, manufacturing, and providing services in the organ transplant industry.

Medical Device Network 4 months ago

GNGBY
Getinge completes the acquisition of Paragonix Technologies

On August 22, 2024, Getinge announced that it had entered into an agreement to acquire Paragonix Technologies, Inc., a leading U.S. company in organ transport products and services, for a total purchase price estimated at USD 477 million, including upfront and currently estimated earn-outs.

PR Newswire 4 months ago

GNGBF

GNGBY
Getinge to buy Paragonix organ-preserving tech for up to $477M

Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.

MedTech Dive 4 months ago

GNGBY
FDA issues 510(k) clearance for Getinge’s Talis +ACG software

The software suite includes Talis-Anesthesia, Talis-Perfusion, Talis-RemoteView, and Talis-ECMO applications.

Medical Device Network 7 months ago

GNGBY
Getinge to limit US sales of heart devices after FDA safety warning

CEO Mattias Perjos said the action will have “some negative financial impact,” but the total effect will depend on customers' response.

MedTech Dive 7 months ago

GNGBY
FDA tells providers to stop using Getinge heart devices

After months of safety concerns, the FDA said Getinge has yet to “sufficiently” address the problems and risks.

MedTech Dive 8 months ago

GNGBY
FDA issues warning on Getinge device amid quality concerns

Following a series of voluntary recalls, the FDA has urged healthcare providers to avoid Getinge’s intra-aortic balloon pumps over safety concerns.

Medical Device Network 8 months ago

GNGBY
UPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devices

The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's heart devices in patients as they faced safety and quality concerns despite a string of recalls. Getinge did not immediately respond to a Reuters request for comment. The FDA suggests providers to move away from the use of Getinge's Cardiosave Hybrid and Rescue Intra-Aortic Balloon Pump (IABP) devices and its Cardiohelp system and HLS Sets.

Reuters 8 months ago

GNGBY
Getinge AB's Dividend Analysis

Getinge AB (GNGBY) recently announced a dividend of $0.42 per share, payable on 2024-05-14, with the ex-dividend date set for 2024-04-23. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Getinge AB's dividend performance and assess its sustainability.

GuruFocus.com 8 months ago

GNGBY

Performance Overview

Return	GTN.BE	OMX Stockholm 30 Index
YTD	+6.13%	+5.41%
1-Year	+10.82%	+12.64%
3-Year	-8.00%	+10.99%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Getinge AB (GTN.BE)

Getinge installs surgical workflow portfolio at UT Health San Antonio in Texas

Two hybrid ORs inaugurated in ASST Sette Laghi hospital, Italy

FDA warns providers on Getinge devices tied to 17 serious injuries

Paragonix wins FDA nod for portable kidney perfusion device

Getinge AB (GNGBF) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Getinge completes Paragonix Technologies acquisition

Getinge completes the acquisition of Paragonix Technologies

Getinge to buy Paragonix organ-preserving tech for up to $477M

FDA issues 510(k) clearance for Getinge’s Talis +ACG software

Getinge to limit US sales of heart devices after FDA safety warning

FDA tells providers to stop using Getinge heart devices

FDA issues warning on Getinge device amid quality concerns

UPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devices

Getinge AB's Dividend Analysis

Performance Overview